Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: An exploratory report from the combining medications to enhance depression outcomes study

Journal of Clinical Psychiatry

Volumn 72, Issue 10, 2011, Pages 1322-1332

  Zisook, Sidney ^a   Lesser, Ira M ^b   Lebowitz, Barry ^c   Rush, A John ^d   Kallenberg, Gene ^a   Wisniewski, Stephen R ^e   Nierenberg, Andrew A ^f   Fava, Maurizio ^f   Luther, James F ^e   Morris, David W ^g   Trivedi, Madhukar H ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ESCITALOPRAM; MIRTAZAPINE; PLACEBO; VENLAFAXINE;

ADULT; AGED; ARTICLE; CHILD ABUSE; CHILD NEGLECT; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT OUTCOME;

EID: 80054952027     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06724     Document Type: Article

References (67)

1. World Health Organization. Suicide rates (per 100,000) by country, year, and sex. 2004. http://www.who.int/mental-health/prevention/suicide/ suiciderates/en/. Accessed June 25, 2010.
2. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005;294(16):2064-2074. doi:10.101/jama.294.16.2064 PubMed (Pubitemid 41539940)
3. Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880. doi:10.136/bmj.b280 PubMed
4. Barbui C, Esposito E, Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ. 2009;180(3):291-297. doi:10.1503/cmaj.081514 PubMed
5. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ. 2005;330(7488):385. doi:10.136/bmj.30.748.385 PubMed
6. Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160(4):790-792. doi:10.176/api.ajp.160.4.790 PubMed (Pubitemid 41079617)
7. Schneeweiss S, Patrick AR, Solomon DH, et al. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Arch Gen Psychiatry. 2010;67(5):497-506. doi:10.101/archgenpsychiatry.2010.39 PubMed
8. Juurlink DN, Mamdani MM, Kopp A, et al. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry. 2006;163(5):813-821. doi:10.176/api.ajp.163.5.813 PubMed (Pubitemid 44464528)
9. Rubino A, Roskell N, Tennis P, et al. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ. 2007;334(7587):242. doi:10.136/bmj.39041.45104.BE PubMed
10. Rush AJ, Trivedi MH, Stewart JW, et al. Combining Medications to Enhance Depression Outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry. 2011;168(7):689-701. doi:10.176/api.ajp.201. 101645 PubMed
11. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11): 1284-1292. doi:10.1097/01.MLR.093487.7864.3C PubMed
12. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.201.01609606.x PubMed (Pubitemid 32823891)
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
15. Combining Medications to Enhance Depression Outcomes Web site. http://www.co-med.org. Accessibility verified August 15, 2011.
16. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008;165(3):342-351. doi:10.176/api.ajp.207.061868 PubMed (Pubitemid 351704490)
17. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry. 2001;58(8):787-794. doi:10.101/archpsyc.58.8.787 PubMed (Pubitemid 32717805)
18. Zimmerman M, Mattia JI. The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Compr Psychiatry. 2001;42(3):175-189. doi:10.1053/comp.201.23126 PubMed (Pubitemid 32410920)
19. Rush AJ, Zimmerman M, Wisniewski SR, et al. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J Affect Disord. 2005;87(1):43-55. doi:10.1016/j.jad.205.03.05 PubMed (Pubitemid 40828202)
20. Trivedi MH, Wisniewski SR, Morris DW, et al. Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry. 2011;72(6):757-764. doi:10.408/JCP.1m06837 PubMed
21. Altman EG, Hedeker D, Peterson JL, et al. The Altman Self-Rating Mania Scale. Biol Psychiatry. 1997;42(10):948-955. doi:10.1016/S06-323(96)0548-3 PubMed (Pubitemid 27486450)
22. Trivedi MH, Wisniewski SR, Morris DW, et al. Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. J Clin Psychiatry. 2011;72(6):765-774. doi:10.408/JCP.1m06840 PubMed
23. Fava M, Iosifescu DV, Pedrelli P, et al. Reliability and validity of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire. Psychother Psychosom. 2009;78(2):91-97. doi:10.159/0201934 PubMed
24. Sangha O, Stucki G, Liang MH, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156-163. doi:10.102/art.1093 PubMed (Pubitemid 36418272)
25. Trivedi MH, Rush AJ, Wisniewski SR, et al.; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement- based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. doi:10.176/api.ajp.163.1.28 PubMed (Pubitemid 43050100)
26. Trivedi MH, Daly EJ. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend. 2007;88(suppl 2):S61-S71. doi:10.1016/j.drugalcdep.207.01.07 PubMed (Pubitemid 46528065)
27. Trivedi MH, Rush AJ, Gaynes BN, et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology. 2007;32(12): 2479-2489. doi:10.1038/sj.np.1301390 PubMed (Pubitemid 350126843)
28. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573-583. Erratum p. 585.
29. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34(1): 73-82. doi:10.1017/ S032917030107 PubMed (Pubitemid 38139442)
30. Rush AJ, Bernstein IH, Trivedi MH, et al. An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a Sequenced Treatment Alternatives to Relieve Depression trial report. Biol Psychiatry. 2006;59(6):493-501. doi:10.1016/j.biopsych.205.08.02 PubMed (Pubitemid 43320536)
31. Wisniewski SR, Rush AJ, Balasubramani GK, et al.; for the STARD Investigators. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract. 2006;12(2):71-79. doi:10.1097/0131746- 206030-02 PubMed (Pubitemid 44284089)
32. Wisniewski SR, Eng H, Meloro L, et al. Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project. Clin Trials. 2004;1(4):387-398. doi:10.191/174074504cn035oa PubMed
33. Fava M. Augmentation and combination strategies in treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 18):4-11. PubMed (Pubitemid 33736199)
34. Papakostas GI, Petersen TJ, Kinrys G, et al. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. J Clin Psychiatry. 2005;66(10):1326-1330. doi:10.408/JCP.v6n1017 PubMed (Pubitemid 41546514)
35. Leuchter AF, Lesser IM, Trivedi MH, et al. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J Psychiatr Pract. 2008;14(5):271-280. doi:10.1097/01.pra. 036754.1956.65 PubMed
36. McGrath PJ, Stewart JW, Fava M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry. 2006;163(9):1531-1541, quiz 1666. doi:10.176/api.ajp.163.9.1531 PubMed
37. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477-486. doi:10.1017/S0329170358 PubMed (Pubitemid 26142491)
38. Rush AJ, Carmody TJ, Reimitz PE. The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res. 2000;9(2):45-59. doi:10.102/mpr.79
39. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353-365. doi:10.2165/019053-19304050-06 PubMed
40. Mundt JC, Marks IM, Shear MK, et al. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180(5):461-464. doi:10.192/bjp.180.5.461 PubMed (Pubitemid 34499343)
41. Frisch MB. Manual and Treatment Guide for the Quality of Life Inventory. Minneapolis, MN: National Computer Systems, Inc; 1994.
42. Frisch MB, Clark MP, Rouse SV, et al. Predictive and treatment validity of life satisfaction and the Quality of Life Inventory. Assessment. 2005;12(1):66-78. doi:10.17/10731910426806 PubMed (Pubitemid 40900463)
43. Levine J, Schooler NR. General versus specific inquiry with SAFTEE. J Clin Psychopharmacol. 1992;12(6):448. doi:10.1097/04714-192120-017 PubMed
44. Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986;22(2):343-381. PubMed (Pubitemid 16043808)
45. Zisook S, Lesser I, Stewart JW, et al. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007;164(10):1539-1546. doi:10.176/api.ajp.207.06101757 PubMed (Pubitemid 350069733)
46. Weissman MM, Wolk S, Goldstein RB, et al. Depressed adolescents grown up. JAMA. 1999;281(18):1707-1713. doi:10.101/jama.281.18.1707 PubMed (Pubitemid 29226480)
47. Claassen CA, Trivedi MH, Rush AJ, et al. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. J Affect Disord. 2007;97(1-3):77-84. doi:10.1016/j.jad.206.05.026 PubMed (Pubitemid 44937416)
48. Morris DW, Trivedi MH, Husain MM, et al. Indicators of pretreatment suicidal ideation in adults with major depressive disorder. Acta Psychiatr Scand. 2010;121(6):480-484. doi:10.1/j.160-047.209.01516.x PubMed
49. Song YM, Smith GD, Sung J. Adult height and cause-specific mortality: a large prospective study of South Korean men. Am J Epidemiol. 2003;158(5):479-485. doi:10.1093/aje/kwg173 PubMed (Pubitemid 37022846)
50. Magnusson PK, Rasmussen F, Lawlor DA, et al. Association of body mass index with suicide mortality: a prospective cohort study of more than one million men. Am J Epidemiol. 2006;163(1):1-8. doi:10.1093/aje/kwj02 PubMed (Pubitemid 43007109)
51. Bjerkeset O, Mykletun A, Dahl AA, et al. Mortality in relation to selfreported mixed anxiety and depression symptoms-The HUNT study. Nord J Psychiatry. 2007;61(1):6-11. doi:10.1080/0803948060121926 PubMed
52. Mukamal KJ, Kawachi I, Miller M, et al. Body mass index and risk of suicide among men. Arch Intern Med. 2007;167(5):468-475. doi:10.101/archinte. 167.5.468 PubMed (Pubitemid 46425659)
53. Maniglio R. The impact of child sexual abuse on health: a systematic review of reviews. Clin Psychol Rev. 2009;29(7):647-657. doi:10.1016/j.cpr.209. 08.03 PubMed
54. Wegman HL, Stetler C. A meta-analytic review of the effects of childhood abuse on medical outcomes in adulthood. Psychosom Med. 2009;71(8):805-812. doi:10.1097/PSY.0b013e3181b2b46 PubMed
55. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry. 2001;49(12):1023-1039. PubMed (Pubitemid 32595461)
56. Kendler KS, Prescott CAA. A population-based twin study of lifetime major depression in men and women. Arch Gen Psychiatry. 1999;56(1):39-44. doi:10.101/archpsyc.56.1.39 PubMed (Pubitemid 29055048)
57. Brodsky BS, Oquendo M, Ellis SP, et al. The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression. Am J Psychiatry. 2001;158(11):1871-1877. doi:10.176/api.ajp.158.1.1871 PubMed (Pubitemid 33054781)
58. Braquehais MD, Oquendo MA, Baca-García E, et al. Is impulsivity a link between childhood abuse and suicide? Compr Psychiatry. 2010;51(2):121-129. doi:10.1016/j.compsych.209.05.03 PubMed
59. Malhotra K, Schwartz T, Hameed U. Presence of suicidality as a prognostic indicator. J Postgrad Med. 2004;50(3):185-187, discussion 187-188. PubMed
60. Healy D, Whitaker C. Antidepressants and suicide: risk-benefit conundrums. J Psychiatry Neurosci. 2003;28(5):331-337. PubMed (Pubitemid 37211275)
61. Olfson M, Marcus SC, Druss BG. Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry. 2008;65(1):94-101. doi:10.101/archgenpsychiatry.207.5 PubMed
62. Tondo L, Baldessarini RJ. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc. 2009;18(3):179-183. PubMed
63. Zisook S, Trivedi MH, Warden D, et al. Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. J Affect Disord. 2009;117(1-2):63-73. doi:10.1016/j.jad.209.01.02 PubMed
64. Mann JJ, Currier D. A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Prog Brain Res. 2008;172: 307-315. PubMed
65. Ryding E, Lindström M, Träskman-Bendz L. The role of dopamine and serotonin in suicidal behaviour and aggression. Prog Brain Res. 2008;172:307-315. doi:10.1016/S079-6123(08)0915-1 PubMed
66. Perroud N, Aitchison KJ, Uher R, et al. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology. 2009;34(12):2517-2528. doi:10.1038/np.209.81 PubMed
67. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105(3):164-172. doi:10.1034/j.160-047.202.1r084.x PubMed (Pubitemid 34280688)